Voss Capital, LP - May 8, 2025 SCHEDULE 13G Report for Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX)

Filing Manager
Voss Capital, LP
Reporting Manager
Voss Capital, LP
Security
Rein Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
RNTX
Shares outstanding
22.8M shares
Disclosed Ownership
1.28M shares
Ownership
5.6%
Form type
SCHEDULE 13G
Date filed
5/14/2025, 08:26 PM
Date of event
May 8, 2025
Next filing
Sep 26, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Voss Value Master Fund, LP 2.5% 583K 583K 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Value-Oriented Special Situations Fund, LP 1.4% 317K 317K 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Advisors GP, LLC 3.9% 900K 900K 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Voss Capital, LP 5.6% 1.28M 1.28M 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Cocke Travis W. 5.6% 1.28M 1.28M 0 /s/ Travis W. Cocke Travis W. Cocke